DPF3, A Putative Candidate Gene For Melanoma Etiopathogenesis in Gray Horses.
Authors: Druml Thomas, Brem Gottfried, Horna Michaela, Ricard Anne, Grilz-Seger Gertrud
Journal: Journal of equine veterinary science
Summary
# Editorial Summary: DPF3 and Melanoma Susceptibility in Gray Horses Melanoma affects over half of gray horses in some populations, yet whilst the STX17 duplication has been identified as a risk factor, the complete genetic architecture underlying this disease remains poorly characterised. Druml and colleagues conducted a genome-wide association study in 141 Lipizzan horses followed by replication across 1,210 horses from seven breeds, identifying a SNP in the DPF3 gene on chromosome 24 as significantly associated with melanoma predisposition. The G/G genotype at this locus demonstrated putative protective effects against melanoma development, suggesting DPF3 may suppress tumour formation—a particularly important finding given that DPF3 encodes a protein involved in regulating cell proliferation, apoptosis and motility in cancer cells. For practitioners managing gray horses, these findings point towards a polygenic basis for melanoma risk beyond STX17 alone, potentially enabling more refined genetic screening and breeding recommendations; however, further functional validation is needed to fully understand how DPF3 variants modulate disease expression and whether genotyping could improve clinical prognostication or inform preventative strategies.
Read the full abstract on PubMed
Practical Takeaways
- •Genetic testing for DPF3 genotypes may help identify gray horses at lower risk for developing melanoma, enabling informed breeding decisions to reduce tumor burden in susceptible lines
- •The G/G genotype carriers appear genetically protected against melanoma development, making them potentially valuable breeding stock for reducing melanoma prevalence in gray horse populations
- •Understanding the genetic basis of melanoma susceptibility beyond STX17 allows veterinarians to provide more accurate prognostic information to owners of gray horses with melanoma history
Key Findings
- •Genome-wide association analysis identified DPF3 on chromosome 24 as a candidate gene involved in melanoma pathogenesis in gray horses
- •The G/G genotype of the DPF3 associated SNP exhibited putative melanoma suppression effects in replication study of 1,210 horses across seven breeds
- •DPF3 gene involvement in cell growth, proliferation, apoptosis and motility suggests a mechanism for genetic melanoma predisposition beyond the previously documented STX17 duplication